Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Cavion
600 East Water Street, Suite E
Charlottesville, VA 22902
Phone: 434-200-8442
http://cavionpharma.com/

Cavion, Inc. is a privately held clinical stage biotechnology company creating therapies modulating the T-type calcium channel (Cav3) for the treatment of neurological and oncologic diseases. Cavion is co-sponsoring a Phase 1 trial of mibefradil combined with hypofractionated radiation therapy for the treatment of recurrent glioblastoma multiforme with the Yale University Comprehensive Cancer Center.

Key Contact
Name
Andrew Krouse
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/06/17 $26,100,000 Series A Lilly Ventures
Novartis Venture Funds
undisclosed